Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Immuron Limited - American Depositary Shares (NQ:IMRN)

2.150 -0.010 (-0.46%)
Streaming Delayed Price Updated: 3:59 PM EDT, Oct 24, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Immuron Limited - American Depositary Shares

< Previous 1 2 3 4 5 6 Next >
Immuron achieves record half yearly Travelan® sales
From Immuron Limited
Via GlobeNewswire
Immuron Clinical Trials Update
From Immuron Limited
Via GlobeNewswire
Immuron Announces First Patients Enrolled in Campylobacter Challenge Clinical Study
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore Investor Webinar Presentation
From Immuron Limited
Via GlobeNewswire
Immuron welcomes launch of Travelan on Amazon US
--News Direct-- 
Via News Direct
FDA Lifts Clinical Hold From Immuron's New Campylobacter ETEC Therapeutic Study
Immuron Limited (NASDAQ: IMRN) has announced that the U.S. 
Via Benzinga
Why Immuron Stock Is Soaring Today
Immuron Ltd (NASDAQ: IMRN) shares are trading higher Monday after the company announced the FDA removed the clinical hold on its new C 
Via Benzinga
Immuron CEO Steven Lydeamore Investor Webinar Presentation
From Immuron Limited
Via GlobeNewswire
Immuron CEO Steven Lydeamore presented at AusBioInvest
From Immuron Limited
Via GlobeNewswire
Immuron Announces Travelan® Clinical Study Cohort 2 commences
From Immuron Limited
Via GlobeNewswire
Immuron achieves record quarterly Travelan® sales
From Immuron Limited
Via GlobeNewswire
Immuron hails record monthly sales of Travelan
Immuron Ltd (NASDAQ:IMRN, ASX:IMC) CEO Steve Lydeamore speaks with Proactive following news the company has achieved record monthly sales of its over-the-counter gastrointestinal supplement Travelan®.... 
Via TheNewswire.com
Immuron hails record monthly sales of Travelan
--News Direct-- 
Via News Direct
Immuron achieves record monthly Travelan® sales
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore to present at H.C. Wainwright
From Immuron Limited
Via GlobeNewswire
Immuron to present at the Military Health System Research Symposium
From Immuron Limited
Via GlobeNewswire
Immuron welcomes launch of Travelan on Amazon US
Immuron Ltd (NASDAQ:IMRN, ASX:IMC) chief commercial officer Flavio Palumbo speaks with Proactive following the news its Travelan product has launched on Amazon US. 
Via TheNewswire.com
Immuron Announces First Patients Enrolled in Travelan® Clinical Study
From Immuron Limited
Via GlobeNewswire
Immuron CEO, Steven Lydeamore to present at Bioshares
From Immuron Limited
Via GlobeNewswire
Immuron Business Update - Ateria Health launches Juvia™ in Australia
From Immuron Limited
Via GlobeNewswire
Immuron FY23 Sales increase 136% on FY22 Sales
From Immuron Limited
Via GlobeNewswire
Immuron Chairman Transition
From Immuron Limited
Via GlobeNewswire
Immuron Business Update: Letter to Shareholders
From Immuron Limited
Via GlobeNewswire
Immuron Initiates Recruitment of Travelan® Clinical Study
From Immuron Limited
Via GlobeNewswire
Global Alzheimer’s Disease Diagnostics & Therapeutics Market Expected to Reach $9.6 Billion by 2027
Palm Beach, FL – May 9, 2023 – FinancialNewsMedia.com News Commentary – Alzheimer’s disease (AD) is a progressive and neurodegenerative disorder that attacks the brain’s nerve cells or neurons, which... 
Via FinancialNewsMedia
Topics Intellectual Property
Nasdaq Edges Higher; Six Flags Reports Upbeat Results
U.S. stocks traded mixed toward the end of trading, with the S&P 500 and Nasdaq Composite turning higher later during the session on Monday. The Dow traded down 0.20% to 33,606.80 while the NASDAQ rose... 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
 
Via Benzinga
Why Tredegar Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Trevena, Inc. (NASDAQ: TRVN) shares surged 170% to $1.74 after the company announced the approval of OLINVYK in China. 
Via Benzinga
Crude Oil Rises Over 2%; US Wholesale Inventories Unchanged For March
U.S. stocks traded slightly lower midway through trading, with the Nasdaq Composite dropping around 20 points on Monday. The Dow traded down 0.14% to 33,626.85 while the NASDAQ fell 0.18% to 12,212.88.... 
Via Benzinga
Palantir (PLTR) Stock Pops Ahead of Earnings
Palantir (PLTR) stock is a hot topic on Monday as investors prepare for the company to report earnings after today's closing bell. 
Via InvestorPlace
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.